We demonstrated that miR-125b was down-regulated in HCC tissues and cell lines and was able to inhibit the cell proliferation and cell cycle progression of HCC cells by targeting Mcl-1 and IL6R. This evidence concerns the gene MCL1 and hepatocellular carcinoma.